Dr. Ryan J. Mattison, MD

Dr. Mattison practices at University Health Services - Madison (Highland Ave) in Madison, Wisconsin.

Dr. Mattison's NPI, 1538184825, was assigned on July 13, 2006. Dr. Mattison graduated from Carver College of Medicine in 2002. Dr. Mattison's Wisconsin license number on file is 52901.

Dr. Mattison's primary practice is University Health Services - Madison (Highland Ave), at 600 Highland Ave, Madison, WI 53792. The practice phone is (608) 265-1978.

Dr. Mattison's primary practice is University Health Services - Madison (Highland Ave) in Madison, Wisconsin. Dr. Mattison is also affiliated with University Hospital. The medical group on file is UW Health. Dmand AI also links Dr. Mattison to 2 more hospitals, each named with a free account. Dr. Mattison's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mattison practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mattison's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mattison is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Mattison's licenses on file in 3 states: Wisconsin, Illinois and North Carolina.

Dmand AI lists chronic leukemia, lymphoma and multiple myeloma among the conditions Dr. Mattison treats.

CMS data shows 711 Medicare services from Dr. Mattison across 6 procedure codes in 2024, for 174 Medicare patients. Medicare paid $30,286 for them.

CMS counts 174 Medicare patients who saw Dr. Mattison in 2024. The largest group is 65 to 74, with 75 patients. 67% of them have high blood pressure, and 65% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mattison's median patient age at 66, with 51% women.

In 2024, Dr. Mattison wrote 991 Medicare Part D claims for 95 patients. 74% of them were for generic drugs. CMS names the drug for 717 of them, across 26 drugs with 11 or more claims each, at $2,282,008 in total drug cost. In 2023, CMS named 767 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Mattison for performance year 2024, reported as part of a group. Dr. Mattison accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mattison as offering telehealth.

Dmand AI links 37 papers to Dr. Mattison, published from 2013 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols and Precursor Cell Lymphoblastic Leukemia-Lymphoma. Dr. Mattison has published most often in Leuk Lymphoma. Dr. Mattison's most frequent co-authors are Richard A. Larson, Mark R. Litzow, MD and Mark B. Juckett, MD.

Dmand AI links Dr. Mattison to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Leukemia, Megakaryoblastic, Acute, Leukemia, Myeloid, Acute and Leukemia, Erythroblastic, Acute.

CMS Open Payments shows 15 general payments to Dr. Mattison from 6 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 79% of the total. Shire North American Group Inc paid the most, $3,108. It also lists 1 research payment totaling $3,200 in 2021.

Dr. Mattison graduated from Carver College of Medicine in 2002.

Dr. Mattison is in network with 20 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.